Corteva, Inc. (CTVA) stock analysis
Close on Nov 10, 2026Market cap $8.12BP/E 8.1Yield 5.75%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid21 of 30 checks passed
Corteva passes 21 of the 30 checks behind our score; 2 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 6/6
- Growth
- 3/6
- Past performance
- 3/6
- Financial health
- 3/6
- Dividend
- 6/6
What stands out
Margin of safety over 20%
The price is 77.9% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $12.17 is below our fair value estimate of $55.12.
Low debt
Debt is 19.4% of shareholders' equity, under the 40% we consider low.
Earnings grew over 5 years
Net income grew 9.9% a year on average over the last five fiscal years.
What to watch
Return on equity under 15%
Return on equity was 4.0% over the last twelve months and averaged 4.5% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew -0.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 0.4% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -28.0% over the last twelve months, against a 5-year average of 9.9% a year.
Valuation6/6
P/E below its 5-year median
Corteva's P/E of 8.1 is below its own 5-year median of 42.8.
P/E below the industry
Corteva's P/E of 8.1 is below the Consumer staples median of 23.3.
EV/EBITDA below its 5-year median
Corteva's EV/EBITDA of 3.8 is below its 5-year median of 18.1.
P/B below the industry
Corteva's price-to-book of 0.32 is below the Consumer staples median of 2.48.
Trading below fair value
The share price of $12.17 is below our fair value estimate of $55.12.
Margin of safety over 20%
The price is 77.9% below fair value, more than the 20% cushion we look for.
Growth3/6
Revenue growing under 10% a year
Revenue grew -0.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 0.4% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -28.0% over the last twelve months, against a 5-year average of 9.9% a year.
Growing faster than the industry
Revenue grew 3.7% over the last twelve months; the Consumer staples median is 1.6%.
Guidance raised
Corteva raised its full-year 2026 Operating EPS outlook on Jul 30, 2026.
Gross margin improving
Gross margin was 49.5% over the last twelve months, against 45.7% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 4.0% over the last twelve months and averaged 4.5% over five years; we look for 15% on both.
Return on invested capital
Needs operating income and invested capital.
Return on equity above the industry
Corteva's return on equity of 4.0% is above the Consumer staples median of 0.9%.
Earnings grew over 5 years
Net income grew 9.9% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 5.7% over the last twelve months, against a 5-year average of 6.7%.
Net margin above the industry
Corteva's net margin of 5.7% is above the Consumer staples median of -6.7%.
Financial health3/6
Low debt
Debt is 19.4% of shareholders' equity, under the 40% we consider low.
Debt rising against equity
Debt to equity rose from 4.5% five years ago to 19.4%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 24.8% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.52 times current liabilities.
Elevated bankruptcy risk
The Altman Z-score is 0.93; above 3 is the safe zone and below 1.8 the distress zone.
Dividend6/6
Pays a dividend
Corteva paid dividends worth 5.9% of the share price over the last twelve months.
Yield above Treasuries
The 5.9% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 3.8% or more; Corteva yields 5.9%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 7 fiscal years.
Covered by earnings
Dividends take 48.0% of net income.
Covered by free cash flow
Dividends take 76.9% of free cash flow.
Fair value
How we estimate itOur estimate per share
$55.12
The share price is 78% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 33.1× | 42.8× | 23.3× | $50.03 | 40% |
| EV/EBITDA | 15.9× | 18.1× | 13.6× | $63.39 | 35% |
| P/B | 2.1× | 1.7× | 2.5× | $77.83 | 10% |
| Earnings power | 8.1% cost of equity | – | – | $34.23 | 15% |
| Fair value | $55.12 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 42.8
- Consumer staples median 23.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $407.51M
- Value traded per 1% price move
- $153.12M
Downside
High risk
- Typical loss in a bad month
- 84.9%
- Volatility (annualized)
- 89%
- Sharpe ratio, 1 year
- -0.96
- Beta to the S&P 500 (5Y)
- 0.64
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2017 to 2025
Gross margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +2.9% | -0.1% | +4.1% | – | |
| Gross profit | +11.5% | +5.4% | +7.6% | – | |
| Net income | +20.6% | -1.6% | +9.9% | – | |
| EPS, diluted | +23.1% | +0.4% | +11.9% | – | |
| Free cash flow | +81.8% | +119.3% | +12.1% | – | |
| Dividend per share | +6.1% | +6.5% | +6.1% | – |
Returns and balance sheet
9 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 2.8% | 4.6% | |
| Return on assets | – | 1.6% | 2.6% | |
| Current ratio | – | 1.73 | 1.43 | |
| Debt to equity | – | 0.04 | 0.11 | |
| Inventory turnover | – | 1.7× | 1.7× | |
| Capex to revenue | – | 3.3% | 3.4% | |
| Diluted shares | – | 751M | 681M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Corteva generated $10.92B from operations and spent $9.93B on capital expenditure, dividends and share buybacks. 30% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 6.3% | 0.42× | 1.75× | 4.6% |
| FY2024 | 5.4% | 0.40× | 1.72× | 3.7% |
| FY2023 | 4.3% | 0.40× | 1.70× | 2.9% |
| FY2022 | 6.6% | 0.41× | 1.68× | 4.5% |
| FY2021 | 11.2% | 0.37× | 1.69× | 7.0% |
| FY2020 | 4.8% | 0.33× | 1.73× | 2.8% |
| FY2019 | -6.9% | 0.18× | 1.53× | -1.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.09B
- Cash generatingOperating cash flow above zero$3.41B
- Return on assets improvedROA up on the prior year2.1% → 2.7%
- Earnings backed by cashOperating cash flow above net income$3.41B vs $1.09B
- Less leverageLong-term debt to assets fell4.8% → 3.9%
- Better liquidityCurrent ratio rose1.45 → 1.43
- No dilutionShare count did not rise696M → 681M
- Gross margin improvedGross margin up on the prior year43.64% → 47.29%
- More efficientAsset turnover rose0.39 → 0.43
See a number that looks wrong?